[HTML][HTML] The evolution of master protocol clinical trial designs: a systematic literature review
EL Meyer, P Mesenbrink, C Dunger-Baldauf… - Clinical Therapeutics, 2020 - Elsevier
Purpose Recent years have seen a change in the way that clinical trials are being
conducted. There has been a rise of designs more flexible than traditional adaptive and …
conducted. There has been a rise of designs more flexible than traditional adaptive and …
Twenty‐five years of confirmatory adaptive designs: opportunities and pitfalls
'Multistage testing with adaptive designs' was the title of an article by Peter Bauer that
appeared 1989 in the German journal Biometrie und Informatik in Medizin und Biologie. The …
appeared 1989 in the German journal Biometrie und Informatik in Medizin und Biologie. The …
Adaptive designs in clinical trials: why use them, and how to run and report them
P Pallmann, AW Bedding, B Choodari-Oskooei… - BMC medicine, 2018 - Springer
Adaptive designs can make clinical trials more flexible by utilising results accumulating in
the trial to modify the trial's course in accordance with pre-specified rules. Trials with an …
the trial to modify the trial's course in accordance with pre-specified rules. Trials with an …
[图书][B] Multiple comparisons using R
Adopting a unifying theme based on maximum statistics, Multiple Comparisons Using R
describes the common underlying theory of multiple comparison procedures through …
describes the common underlying theory of multiple comparison procedures through …
The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an …
Adaptive designs (ADs) allow pre-planned changes to an ongoing trial without
compromising the validity of conclusions and it is essential to distinguish pre-planned from …
compromising the validity of conclusions and it is essential to distinguish pre-planned from …
[图书][B] Multiple testing problems in pharmaceutical statistics
Bringing together leading statisticians, scientists, and clinicians from the pharmaceutical
industry, academia, and regulatory agencies, this volume explores the rapidly growing area …
industry, academia, and regulatory agencies, this volume explores the rapidly growing area …
Adaptive trial designs: a review of barriers and opportunities
Adaptive designs allow planned modifications based on data accumulating within a study.
The promise of greater flexibility and efficiency stimulates increasing interest in adaptive …
The promise of greater flexibility and efficiency stimulates increasing interest in adaptive …
HIV prevention interventions for adolescents
S Hosek, A Pettifor - Current HIV/AIDS Reports, 2019 - Springer
Abstract Purpose of Review The goal of this paper is to review recent data on biomedical,
behavioral, and structural HIV prevention interventions for adolescents and young adults …
behavioral, and structural HIV prevention interventions for adolescents and young adults …
Brightline-1: phase II/III trial of the MDM2–p53 antagonist BI 907828 versus doxorubicin in patients with advanced DDLPS
P Schöffski, M Lahmar, A Lucarelli, RG Maki - Future Oncology, 2023 - Taylor & Francis
Dedifferentiated liposarcoma (DDLPS) is a rare, aggressive liposarcoma associated with
poor prognosis. First-line treatment for advanced/metastatic DDLPS is systemic …
poor prognosis. First-line treatment for advanced/metastatic DDLPS is systemic …
Efficient adaptive designs for clinical trials of interventions for COVID-19
N Stallard, L Hampson, N Benda… - Statistics in …, 2020 - Taylor & Francis
The COVID-19 pandemic has led to an unprecedented response in terms of clinical
research activity. An important part of this research has been focused on randomized …
research activity. An important part of this research has been focused on randomized …